14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate

 化学構造式
76958-99-1
CAS番号.
76958-99-1
化学名:
别名:
英語名:
14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate
英語别名:
Ddhads;Dehydroandrographolide Succinate Potasium Salt;14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate;14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate USP/EP/BP;Kalii Dehydrographolidi Succinas,inhibit,Potassium dehydroandrographolide,Inhibitor;Potassium 4-(((1R,2R,4aR,5R,8aS)-2-((3-carboxypropanoyl)oxy)-1,4a-dimethyl-6-methylene-5-((E)-2-(2-oxo-2,5-dihydrofuran-3-yl)vinyl)decahydronaphthalen-1-yl)methoxy)-4-oxobutanoate;potassium,4-[[(1R,2R,4aR,5R,8aS)-2-(3-carboxypropanoyloxy)-1,4a-dimethyl-6-methylidene-5-[(E)-2-(5-oxo-2H-furan-4-yl)ethenyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]-4-oxobutanoate
CBNumber:
CB21312083
化学式:
C28H37KO10
分子量:
572.69
MOL File:
76958-99-1.mol

14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate 物理性質

安全性情報
  • リスクと安全性に関する声明
  • 危険有害性情報のコード(GHS)
絵表示(GHS) GHS hazard pictograms
注意喚起語 警告
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード
H302 飲み込むと有害 急性毒性、経口 4 警告 GHS hazard pictograms P264, P270, P301+P312, P330, P501
H315 皮膚刺激 皮膚腐食性/刺激性 2 警告 GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 強い眼刺激 眼に対する重篤な損傷性/眼刺激 性 2A 警告 GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 呼吸器への刺激のおそれ 特定標的臓器毒性、単回暴露; 気道刺激性 3 警告 GHS hazard pictograms
注意書き
P261 粉じん/煙/ガス/ミスト/蒸気/スプレーの吸入を避ける こと。
P305+P351+P338 眼に入った場合:水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。

14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate 化学特性,用途語,生産方法

説明

This product was included in national standards for chemical drugs.
Injection, freeze-dried powder injection. Used for viral pneumonia and viral upper respiratory tract infection

物理的性質

Appearance: white to yellowish crystalline powder, odorless, bitter, slightly wetting. Solubility: slightly soluble in ethanol, insoluble in chloroform, dissolved in 1% sodium bicarbonate solution.

来歴

Andrographolide is unable to satisfy the clinical requirement due to the poor water solubility. Since the 1970s, researchers had tried to increase the water solubility through the introduction of different hydrophilic groups in the structure of lactone and had developed a variety of Andrographis lactone injection. Among them, potassium dehydroandrographolide succinate has the strongest anti-inflammatory and antipyretic effect. The synthetize of potassium dehydroandrographolide succinate is as follow described: the formation starts with andrographolide as an intermediate, after succinic anhydride reaction catalyzed by pyridine, dehydrated andrographolide succinate half ester was formed then reacted in dilute ethanol solution and potassium bicarbonate to form the final production . Potassium dehydroandrographolide succinate is known as natural antibiotics, and its anti-inflammatory effect is the best among the 13 andrographolide injections, which has been listed as the top 10 Chinese emergency medicines by the National Chinese Medicine Administration and has been listed as the first batch of necessary drugs for the National Chinese Hospital of emergency department .

適応症

This product is contained in the Pharmacopoeia of the People’s Republic of China (2010). Injection, freeze-dried powder injection. Used for viral pneumonia and viral upper respiratory tract infection.

薬理学

Potassium dehydroandrographolide succinate and potassium sodium dehydroandrographolide succinate have the same substance of active metabolites in the body (andrographolide half ester monopotassium salt). As for antipyretic, anti-inflammatory, and antiviral activity, it can promote the anterior pituitary biosynthesis and release of ACTH and alleviate inflammation through the inhibition of histamineinduced increase in capillary permeability and stimulation to pituitary-adrenal cortical function at the designated site. It can inhibit the binding of DNA with protein in the process of virus replication, as well as inhibit bacterial endotoxin-induced fever. It can inactivate adenovirus, influenza virus, respiratory virus, and other viruses and also inhibit Staphylococcus aureus, Streptococcus aureus, etc. Clinically, it is used for the treatment of upper respiratory tract infection, bronchial pneumonia, viral pneumonia, viral enteritis, and hand, foot, and mouth disease .

臨床応用

Potassium dehydroandrographolide succinate is widely used in the treatment of viral pneumonia, influenza virus-induced acute upper respiratory tract infection, acute bronchitis, pediatric bronchial pneumonia, dysentery, epidemic encephalitis, and asthma attacks, especially for viral and bacterial respiratory tract infections, and has a significant effect on dysentery, especially for infant pneumonia . Clinically, potassium sodium dehydroandrographolide succinate is mainly used for the treatment of upper respiratory tract infection, bronchial pneumonia, viral pneumonia, viral enteritis, and hand, foot, and mouth disease .

副作用

The adverse reactions of allergic reactions infusion after intravenous drip of potassium dehydroandrographolide succinate were reported most, some of them emerge of pimples, abdominal pain, vomiting, dizziness, head swelling, severe cases, however the sever of them may occur life-threatening anaphylactic shock. The reactions occurred within 20?min and usually gradually improved in 5–45?min after symptomatic treatment. There are individuals needing 24? min to start to recover. In addition, there is also chance to occur thrombocytopenia, liver damage, blood vessels to stimulate pain, difficulty in breathing, chills, fever, etc. after the use of potassium dehydroandrographolide succinate . Skin allergies and diarrhea often occur in children after intravenous drip of potassium sodium dehydroandrographolide succinate, occasionally allergic shock and liver damage reports. Serious adverse reactions of potassium sodium dehydroandrographolide succinate injection are systemic damage; the main symptoms contain allergic shock, allergic reactions, chills, fever, etc., while skin and accessories damage mainly occur rash, of which 53% of patients is children under the age of 14, 38% of deaths caused by drug-induced allergic shock. According to the 23rd issue of “adverse drug reactions” published by the National Drug Adverse Drug Reaction Center, the irrational use of potassium sodium dehydroandrographolide succinate mainly includes overdose, cross-indications, and allergic constitution .

14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate 上流と下流の製品情報

原材料

準備製品


14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate 生産企業

Global( 61)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Chengdu Biopurify Phytochemicals Ltd.
+8618080483897
sales@biopurify.com China 3424 58
Shaanxi Pioneer Biotech Co., Ltd .
+8613259417953
sales@pioneerbiotech.com China 3000 58
Wuhan ChemNorm Biotech Co.,Ltd.
+86-27-8439 4403 18971486879
sales@chemnorm.com CHINA 2935 58
ANHUI WITOP BIOTECH CO., LTD
+8615255079626
eric@witopchemical.com China 23556 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250
1026@dideu.com China 28761 58
Hong Kong Excellence Biotechnology Co., Ltd.
+86-86-18838029171 +8618126314766
ada@sh-teruiop.com China 893 58
TargetMol Chemicals Inc.
+1-781-999-5354
support@targetmol.com United States 19973 58
Shandong Hanjiang Chemical Co., Ltd
+86-0533-2066820 +8618369939125
hanson@sdhanjiang.com China 889 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 57511 58
ChemCell Biomedicine Co.,Ltd. 020-13556033878 2965585218 13556033878
chemcell@hotmail.com China 369 52

76958-99-1()キーワード:


  • 76958-99-1
  • 14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate
  • Dehydroandrographolide Succinate Potasium Salt
  • 14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate USP/EP/BP
  • Ddhads
  • Kalii Dehydrographolidi Succinas,inhibit,Potassium dehydroandrographolide,Inhibitor
  • potassium,4-[[(1R,2R,4aR,5R,8aS)-2-(3-carboxypropanoyloxy)-1,4a-dimethyl-6-methylidene-5-[(E)-2-(5-oxo-2H-furan-4-yl)ethenyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]-4-oxobutanoate
  • Potassium 4-(((1R,2R,4aR,5R,8aS)-2-((3-carboxypropanoyl)oxy)-1,4a-dimethyl-6-methylene-5-((E)-2-(2-oxo-2,5-dihydrofuran-3-yl)vinyl)decahydronaphthalen-1-yl)methoxy)-4-oxobutanoate
Copyright 2017 © ChemicalBook. All rights reserved